Skip to content
FocusPro Blog

Social Media Content Creators Fueling Unofficial Market for Unapproved Weight-Loss Medication

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of uncertain source.

Some professionals said the popularity for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company said it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Online Trading Operations

Investigations also found communities with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, populated with images of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.

After moments of joining one group, a seller shared WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Product Details and Costs

Within these communities, posts show black plastic packages with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially serious medical dangers”.

The writer

Jared Herrera

Elena is a digital productivity consultant with over a decade of experience helping professionals optimize their workflows and leverage technology effectively.

FocusPro Blog

Type to search articles.